Volume 2, Issue 3 (Spring 2011 -- 2011)                   BCN 2011, 2(3): 51-57 | Back to browse issues page

XML Print


Abstract:  

Introduction:

Hyperalgesia is considered as one of the marked signs of subchronic diabetes mellitus in patients that could affect their lifestyle. This study was designed to investigate the anti-nociceptive effect of chronic administration of quercetin in streptozotocin (STZ)-diabetic rats using formalin and hot tail immersion tests.

Methods:

Rats were divided into control, control or diabetic groups receiving sodium salicylate, untreated diabetic, and quercetin-treated control and diabetic groups. The treatment groups received i.p. administration of quercetin at a dose of 10 mg/kg for 6 weeks. Finally, hyperalgesia were assessed using standard formalin and hot tail immersion tests. Meanwhile, some markers of oxidative stress were also measured in brain tissue.

Results:

Quercetin or SS treatment of diabetic rats significantly reduced pain score in chronic phase of formalin test (p<0.05). Regarding hot tail immersion test, diabetic rats showed a significant reduction in tail flick latency as compared to control ones (p<0.05) and quercetin treatment of diabetic rats did significantly increase this latency relative to untreated diabetics (p<0.05). Quercetin treatment of diabetic rats also significantly decreased brain level of malondialdehyde (MDA) (p<0.05) and nitrite (p<0.05) and slightly increased activity of superoxide dismutase (SOD) relative to diabetics.

Discussion:

Taken together, chronic administration of quercetin could attenuate nociceptive score in chronic phase of formalin test in streptozotocin-diabetic rats and could also increase threshold of thermal nociception.

 

 

Type of Study: Original | Subject: Clinical Neuroscience
Received: 2012/01/3 | Published: 2011/04/15

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.